REGENXBIO, Inc. (RGNX)
13.79
-2.19
(-13.70%)
USD |
NASDAQ |
Jan 23, 16:00
14.06
+0.27
(+1.96%)
After-Hours: 20:00
REGENXBIO Research and Development Expense (TTM): 203.30M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Omeros Corp. | 84.14M |
| AbbVie, Inc. | 8.815B |
| Krystal Biotech, Inc. | 55.37M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 11.68M |